Registered entities
Ashvattha Therapeutics, Inc
Reg. No. 474803849United States
Innovation
10 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 1,120 times.
| Year | Filings |
|---|---|
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 1 |
Social engagement
Social engagement: 4K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Huadong Medicine, Tribe Capital, Natural Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 69% |
| Other / undisclosed | 4 | 31% |
Recent activity
8 Jan 2026
Leadership hire
Executive Chairman
22 Nov 2025
Leadership hire
Chief Medical Officer
17 Nov 2025
Event
Fefferies Global Healthcare Conference, Ophthalmology Innovation Source,FLORetina 2025 Congress, Eyenovate